Last reviewed · How we verify
NCT06281015: IATOS
Artificial Intelligence and Bone Tomoscintigraphies Achieved With CZT Camera
trial testing Whole-body bone single photon emission tomography (SPECT) for detection or follow-up of bone metastasis in Bone Lesion in 19 participants. Completed in 30 October 2023.
10 September 2023
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 19 |
| Start date | 30 August 2023 |
| Primary completion | 10 September 2023 |
| Estimated completion | 30 October 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Whole-body bone single photon emission tomography (SPECT) for detection or follow-up of bone metastasis
Conditions studied
- Bone Lesion — all drugs for Bone Lesion →
Sponsor
Central Hospital, Nancy, France
Who can join
Adults 18 to 95, any sex, with Bone Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to determine whether the whole-body bone Single Photon Emission Computed Tomography (SPECT) recording times of around 10 minutes, routinely provided by a high-sensitivity 360 degrees cadmium and zinc telluride (CZT) camera, can be further reduced by a deep learning noise reduction (DLNR) algorithm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06281015
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Lesion
Currently open trials in the same condition.
- NCT06754137 — Assessing AI-Supported Fracture Detection in Emergency Care Units · NA · recruiting
- NCT06249906 — Efficacy of Bioceramic Materials for Bone Defects Repair · NA · recruiting
- NCT05934994 — Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions · NA · recruiting
- NCT04307914 — Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases · NA · active not recruiting
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06281015 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06281015.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing